Michael Mark

Learn More
Linagliptin (TRADJENTA™) is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor. DPP-4 inhibition attenuates insulin resistance and improves peripheral glucose utilization in humans. However, the effects of chronic DPP-4 inhibition on insulin sensitivity are not known. The effects of long-term treatment (3-4 weeks) with 3 mg/kg/day or 30 mg/kg/day(More)
—This paper deals with system level design considerations for mm-size implantable electronic devices with wireless connectivity. In particular, it focuses on neural sensors as one application requiring such miniature interfaces. Common to all these implants is the need for power supply and a wireless interface. Wireless power transfer via electromagnetic(More)
The PicoCube is a 1cm 3 sensor node using harvested energy as its source of power. Operating at an average of only 6uW for a tire-pressure application, the PicoCube represents a modular and integrated approach to the design of nodes for wireless sensor networks. It combines advanced ultra-low power circuit techniques with system-level power management. A(More)
  • Heike Zimdahl, Carina Ittrich, Ulrike Graefe-Mody, Bernhard O. Boehm, Michael Mark, Hans-Juergen Woerle +1 other
  • 2014
AIMS/HYPOTHESIS Individuals carrying variants of the transcription factor 7-like 2 gene (TCF7L2) are at increased risk for type 2 diabetes. These metabolic genetic risk factors have been linked to diminished pancreatic islet-cell responsiveness to incretins, thus pharmacological interventions aimed at amplifying endogenous incretin biology may be affected.(More)
This copy has been supplied on the understanding that it is copyright material. Duplication or sale of all or part of any of the GRO Data Collections is not permitted, and no quotation or excerpt from the work may be published without the prior written consent of the copyright holder/s. Abstract In order to cooperate effectively with its peers, an agent(More)
  • Arnoud J Templeton, Beat Thürlimann, Michael Baumann, Michael Mark, Sarah Stoll, Madeleine Schwizer +2 others
  • 2012
Besides conventional adjuvant therapies, many breast cancer survivors engage in various activities like exercise, diet and complementary and alternative medicine (CAM) in order to improve their prognosis. Little is known about specific interests and willingness to participate in institutional programs (e.g. exercise classes). We conducted a cross-sectional(More)
  • 1